Confo Therapeutics expands board with appointment of Rob Scott as Independent Director10. June 2020|In Portfolio News|By eazee-designstudioConfo Therapeutics today announced the appointment of Rob Scott as an Independent Director. Dr. Scott’s career spans 30 years of drug discovery and development leadership in the global pharmaceutical and biotechnology industries, including his last position as Chief Medical Officer, Head of Development at AbbVie. PrevNext
